Accéder au contenu
Merck
Toutes les photos(3)

Principaux documents

200689

Sigma-Aldrich

Éthyl cellulose

viscosity 10 cP, 5 % in toluene/ethanol 80:20(lit.), extent of labeling: 48% ethoxyl

Synonyme(s) :

ethylcellulose

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Numéro CAS:
Numéro MDL:
Code UNSPSC :
12162002
Nomenclature NACRES :
NA.23

Forme

powder

Température d'inflammation spontanée

698 °F

Ampleur du marquage

48% ethoxyl

Indice de réfraction

n20/D 1.47 (lit.)

Viscosité

10 cP, 5 % in toluene/ethanol 80:20(lit.)

Température de transition

softening point 155 °C

Densité

1.14 g/mL at 25 °C (lit.)

Chaîne SMILES 

O1[C@H](C(C(C(C1COCC)OCC)OCC)OCC)O[C@@H]2C(OC(C(C2OCC)OCC)OCC)COCC

Clé InChI

MINRZDZESGXKDM-OLIDUAMRSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

Ethyl cellulose(EC) is a hydrophobic andphysiologically inert cellulose derivative. It is widely used to preparephysiological dosage forms. It can also be used as a polymer coating,particle emulsion stabilizer and in pharmaceuticallyuseful aqueous latex dispersions.

Application

Ethyl cellulose can be used as a starting material to prepare zein-based nanofibers for controlled drug release. The addition of EC improves the solubility and mechanical properties of the composite nanofibers.

It can be used to prepare graphene-based ink for inkjet printing. This graphene oxide ink printed onto ITO surfaces can be used as an electrode for label-free DNA sensing.

Owing to its unique features such as gastroresistance, biocompatibility, and degradation to non-toxic and readily excreted products, EC is widely used in oral and topical drug dosage forms for the controlled release of the drug.

Caractéristiques et avantages

  • Non-toxic
  • Stable
  • Compressible

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 1

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Équipement de protection individuelle

Eyeshields, Gloves, type N95 (US)


Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Arif Z Nelson et al.
Proceedings of the National Academy of Sciences of the United States of America, 117(11), 5671-5679 (2020-03-05)
Microfluidic tools and techniques for manipulating fluid droplets have become core to many scientific and technological fields. Despite the plethora of existing approaches to fluidic manipulation, non-Newtonian fluid phenomena are rarely taken advantage of. Here we introduce embedded droplet printing-a
Daniela Traini et al.
International journal of pharmaceutics, 438(1-2), 150-159 (2012-09-12)
The potential of excipient coating to enhance aerosol performance of micronized drugs in carrier excipient-drug blends, used in dry powder inhalers, was investigated. Both EC (ethyl cellulose) and PVP (polyvinylpyrrolidone) were used as coating agents. Carriers were prepared via sieve
Oguzhan Gunduz et al.
Pharmaceutical research, 30(1), 225-237 (2012-09-08)
To investigate a new microfluidic method for the continuous preparation of hollow-shell nanoparticles of a hydrophobic polymer and the simultaneous encapsulation within these of a hydrophilic active pharmaceutical ingredient. A specially designed and constructed microfluidic device which facilitates at a
Kifayat Ullah Shah et al.
TheScientificWorldJournal, 2012, 842348-842348 (2012-06-01)
The design and fabrication of sustained/controlled release dosage forms, employing new excipients capable of extending/controlling the release of drugs from the dosage forms over prolonged periods, has worked well in achieving optimally enhanced therapeutic levels of the drugs. In this
Tetsuya Ozeki et al.
Biological & pharmaceutical bulletin, 35(11), 1926-1931 (2012-11-06)
Production of drug nanoparticles is an effective strategy to enhance solubility and oral absorption of water-insoluble drugs. The handling of drug nanoparticles has been an important issue in drug formulation because nanoparticles easily aggregate each other and redispersion of these

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique